Cancer can be one of the most difficult things to live with, and for those fighting it at 80, treatments can be even more trying.

Increasingly, scientists are linking inflammation with cancer. A classic drug choice to treat inflammation is aspirin. Is this drug ready for primetime in the cancer fight? Well, it depends who you ask.

People living with colorectal cancer that has spread to other areas of the body now have a new therapy option. Unlike so many late-stage cancer treatments, this isn’t an intravenous drug - rather, a tablet.

Colorectal cancer screening rates could be better. Most people just don’t want to mess with the tests or the expenses of these screenings. These already low rates are even lower among poor people, racial minorities and people who don’t speak English very well.

Higher fitness levels bring lots of benefits to individuals in the now. It helps keep away illnesses and makes the body strong. And fitness also has an effect way down the road by adding years to life, but its quality had been in question.

Trillions of bacteria - that's right trillions with a "t" - are found inside the lining of the colon. When inflammation enters the picture, that's when trouble can start. The bacteria and inflammation can team up and become a deadly duo.

A compound found in vegetables such as broccoli, cauliflower and kale has been studied for its effect on cancer. Recently, its potential benefits may have been expanded.

The U.S. Food and Drug Administration has approved a new drug to treat advanced colorectal cancer. The medication extends the lives of those living with colorectal cancer that has spread to other organs (metastasized) by about 45 days.

For years, it's been thought that colon cancer differed from rectal cancer. After all, they are two different diseases, occurring in two different organs. Right? Recent research has shown that the two diseases may not be different at all.